|
業務類別
|
Real Estate Services |
|
業務概覽
|
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targetingtherapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel. |
| 公司地址
| 520 Broad Street, Newark, NJ, USA, 07102 |
| 電話號碼
| +1 212 658-1450 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.rafaelholdings.com |
| 員工數量
| 23 |
| Mr. Howard S. Jonas |
Chief Executive Officer, President, Chairman of the Board and Executive Chairman |
美元 44.00K |
18/11/2025 |
| Mr. David Polinsky |
Chief Financial Officer and Principal Accounting Officer |
美元 300.01K |
18/11/2025 |
| Mr. Joshua M. Fine |
Chief Operating Officer |
-- |
07/08/2025 |
|
|
| Mr. Howard S. Jonas |
Chief Executive Officer, President, Chairman of the Board and Executive Chairman |
18/11/2025 |
| Mr. N. Scott Fine |
Vice Chairman of the Board |
18/11/2025 |
| Mr. Markus W. Sieger |
Lead Independent Director |
28/10/2025 |
| Dr. Michael J. Weiss, M.D. |
Independent Director |
18/11/2025 |
| Ms. Susan Y. Bernstein |
Director |
18/11/2025 |
| Dr. Mark N. Stein, M.D. |
Independent Director |
18/11/2025 |
| Mr. Alan Grayson |
Director |
28/10/2025 |
|
|
|
|
